Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
基本信息
- 批准号:7837499
- 负责人:
- 金额:$ 26.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcuteAddressAnimal WelfareAntiviral AgentsAntiviral ResponseApicalAsthmaBibliographyBiometryCenter for Translational Science ActivitiesClinicalConsultCountryCritiquesEnvironmentEnvironmental ImpactEpithelial CellsEpitheliumEquipmentEventFutureGenerationsGenesHeadHealth SciencesHost DefenseHourHumanHydrogen PeroxideIACUCInfectionInterleukin-13Interleukin-4InternationalKnowledgeLiteratureLungMediatingModelingPatientsPrincipal InvestigatorProductionProteinsPublic HealthReactive Nitrogen SpeciesResearchResearch Ethics CommitteesResourcesRespiratory SystemRespiratory tract structureRhinovirusServicesSignal PathwaySystemTestingTimeUp-RegulationVertebratesViralVirus DiseasesW7 (Calmodulin Antagonist)abstractingairway epitheliumasthmatic patientcytokineexpirationhuman subjectnovelpathogenprofessorprograms
项目摘要
Rhinovirus (RV) is an important pathogen present in the respiratory tract epithelium of a significant proportion of asthma patients during severe pulmonary exacerbations. Mechanisms by which the human respiratory tract epithelium identifies acute RV infection, mechanisms used immediately by the human respiratory tract epithelium to respond to this infection, and how these mechanisms are impaired in asthmatics have not been fully elucidated. Our recent studies of DUOX2 suggest this protein is critical for normal antiviral host defense. We hypothesize that DUOX2 is a central component for host defense against RV infection in respiratory tract epithelium: When activated by RV, DUOX2 produces hydrogen peroxide (H2O2), hypohalous acid, or reactive nitrogen species to (a) directly inactivate rhinovirus and (b) stimulate the expression of early antiviral genes, but (c) antiviral activity is suppressed in the presence of Th2 cytokines such as interleukin-4 (IL- 4) or interleukin-13 (IL-13). Specific Aims: Test the predictions that (1) DUOX2-mediated generation of H2O2, hypohalous acids, or reactive nitrogen species directly inactivates RV, (2) DUOX2- mediated generation of H2O2 results in the early activation of antiviral genes, and (3) IL-4 blocks DUOX2-mediated antiviral activity by inhibiting transcriptionally-mediated DUOX2 expression. We will use human respiratory tract epithelial cells for all the studies outlined for this project. Relevance to Public Health - Rhinovirus (RV) is an important pathogen present in the respiratory tract epithelium of a significant proportion of asthma patients during severe pulmonary exacerbations. Our recent studies of DUOX2 suggest this protein is critical for normal antiviral host defense. We anticipate our studies will reveal novel mechanisms by which the respiratory tract epithelium activates innate host defense against RV infection. These studies will potentially elucidate specific mechanisms that are impaired in asthmatic patients.
鼻病毒(RV)是在严重肺部恶化期间大部分哮喘患者的呼吸道上皮中存在的重要病原体。人类呼吸道上皮鉴定急性RV感染的机制,人呼吸道上皮立即使用以应对这种感染的机制,以及在哮喘患者中如何损害这些机制。我们最近对DUOX2的研究表明,该蛋白对于正常的抗病毒宿主防御至关重要。 We hypothesize that DUOX2 is a central component for host defense against RV infection in respiratory tract epithelium: When activated by RV, DUOX2 produces hydrogen peroxide (H2O2), hypohalous acid, or reactive nitrogen species to (a) directly inactivate rhinovirus and (b) stimulate the expression of early antiviral genes, but (c) antiviral activity is suppressed in the presence of Th2细胞因子,例如白介素4(IL-4)或白介素13(IL-13)。具体目的:测试(1)DUOX2介导的H2O2,低孔酸或反应氮的产生直接失活的RV,(2)DUOX2-介导的H2O2产生H2O2导致早期激活抗病毒基因的早期激活,(3)IL-4阻断DUOX2 DUOX2介导的抗激发作用,并通过抗激发作用进行了抗激活,并通过抗激发作用进行了抗激活。我们将使用人类呼吸道上皮细胞进行该项目概述的所有研究。与公共卫生 - 鼻病毒(RV)相关的是,在严重的肺部恶化期间,大部分哮喘患者的呼吸道上皮中存在重要的病原体。我们最近对DUOX2的研究表明,该蛋白对于正常的抗病毒宿主防御至关重要。我们预计我们的研究将揭示新的机制,通过这种机制,呼吸道上皮会激活对RV感染的先天宿主防御。这些研究可能会阐明哮喘患者受损的特定机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richart W Harper其他文献
Richart W Harper的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richart W Harper', 18)}}的其他基金
Defining Breath VOC Biomarkers to Improve Respiratory Health of Exposed Veterans
定义呼吸 VOC 生物标志物以改善接触过的退伍军人的呼吸健康
- 批准号:
10015032 - 财政年份:2021
- 资助金额:
$ 26.38万 - 项目类别:
Defining Breath VOC Biomarkers to Improve Respiratory Health of Exposed Veterans
定义呼吸 VOC 生物标志物以改善接触过的退伍军人的呼吸健康
- 批准号:
10553150 - 财政年份:2021
- 资助金额:
$ 26.38万 - 项目类别:
Defining Breath VOC Biomarkers to Improve Respiratory Health of Exposed Veterans
定义呼吸 VOC 生物标志物以改善接触过的退伍军人的呼吸健康
- 批准号:
10355416 - 财政年份:2021
- 资助金额:
$ 26.38万 - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
7370003 - 财政年份:2008
- 资助金额:
$ 26.38万 - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
7561050 - 财政年份:2008
- 资助金额:
$ 26.38万 - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
8215722 - 财政年份:2008
- 资助金额:
$ 26.38万 - 项目类别:
Duox2 Modulation of Viral Infection in Airway Epithelium
Duox2 调节气道上皮病毒感染
- 批准号:
7758765 - 财政年份:2008
- 资助金额:
$ 26.38万 - 项目类别:
Thioredoxin localization and its function in the airway
硫氧还蛋白定位及其在气道中的功能
- 批准号:
6933806 - 财政年份:2001
- 资助金额:
$ 26.38万 - 项目类别:
Thioredoxin localization and its function in the airway
硫氧还蛋白定位及其在气道中的功能
- 批准号:
6653908 - 财政年份:2001
- 资助金额:
$ 26.38万 - 项目类别:
Thioredoxin localization and its function in the airway
硫氧还蛋白定位及其在气道中的功能
- 批准号:
6327134 - 财政年份:2001
- 资助金额:
$ 26.38万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 26.38万 - 项目类别:
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach
用于治疗胰腺炎的降胆固醇药物:验证具有临床意义的新型治疗靶点和方法
- 批准号:
10585773 - 财政年份:2023
- 资助金额:
$ 26.38万 - 项目类别:
The lipid hydrolase NAAA as a target for non-addictive analgesic medications
脂质水解酶 NAAA 作为非成瘾性镇痛药物的靶标
- 批准号:
10584428 - 财政年份:2023
- 资助金额:
$ 26.38万 - 项目类别:
Liver Targeting Dihydroquinolizinone (DHQ) Molecules as Hepatitis B Virus Antivirals with Reduced Toxicity
肝脏靶向二氢喹嗪酮 (DHQ) 分子作为乙型肝炎病毒抗病毒药物,毒性降低
- 批准号:
10593566 - 财政年份:2023
- 资助金额:
$ 26.38万 - 项目类别:
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
- 批准号:
10600887 - 财政年份:2023
- 资助金额:
$ 26.38万 - 项目类别: